[go: up one dir, main page]

AU2002351240A1 - Gold nanoparticles used for x-rays imaging - Google Patents

Gold nanoparticles used for x-rays imaging

Info

Publication number
AU2002351240A1
AU2002351240A1 AU2002351240A AU2002351240A AU2002351240A1 AU 2002351240 A1 AU2002351240 A1 AU 2002351240A1 AU 2002351240 A AU2002351240 A AU 2002351240A AU 2002351240 A AU2002351240 A AU 2002351240A AU 2002351240 A1 AU2002351240 A1 AU 2002351240A1
Authority
AU
Australia
Prior art keywords
gold nanoparticles
nanoparticles used
rays imaging
rays
imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351240A
Other versions
AU2002351240A8 (en
Inventor
James Hainfeld
Daniel Slatkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002351240A1 publication Critical patent/AU2002351240A1/en
Publication of AU2002351240A8 publication Critical patent/AU2002351240A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • A61K49/0414—Particles, beads, capsules or spheres
    • A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
    • A61K49/0428—Surface-modified nanoparticles, e.g. immuno-nanoparticles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2002351240A 2002-03-08 2002-12-04 Gold nanoparticles used for x-rays imaging Abandoned AU2002351240A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9404102A 2002-03-08 2002-03-08
US10/094,041 2002-03-08
PCT/US2002/038850 WO2003075961A2 (en) 2002-03-08 2002-12-04 Gold nanoparticles used for x-rays imaging

Publications (2)

Publication Number Publication Date
AU2002351240A1 true AU2002351240A1 (en) 2003-09-22
AU2002351240A8 AU2002351240A8 (en) 2003-09-22

Family

ID=27804244

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351240A Abandoned AU2002351240A1 (en) 2002-03-08 2002-12-04 Gold nanoparticles used for x-rays imaging

Country Status (2)

Country Link
AU (1) AU2002351240A1 (en)
WO (1) WO2003075961A2 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1622649A2 (en) * 2003-05-06 2006-02-08 Philips Intellectual Property & Standards GmbH Apparatus and method for examining an object by means of elastically scattered x-ray radiation and contrast agent
US20070031339A1 (en) * 2003-11-28 2007-02-08 Oskar Axelsson Contrast agents
US20070003482A1 (en) * 2004-01-15 2007-01-04 Koninklijke Philips Electronic, N.V. Ultrasound contrast agents for molecular imaging
NO20052428D0 (en) * 2005-05-20 2005-05-20 Amersham Health As contrast agents
NO20052429D0 (en) * 2005-05-20 2005-05-20 Amersham Health As The contrast agents
US9149545B2 (en) 2005-11-02 2015-10-06 General Electric Company Nanoparticle-based imaging agents for X-ray/computed tomography and methods for making same
US20070122620A1 (en) * 2005-11-02 2007-05-31 General Electric Company Nanoparticle-based imaging agents for x-ray / computed tomography and methods for making same
US8003883B2 (en) 2007-01-11 2011-08-23 General Electric Company Nanowall solar cells and optoelectronic devices
US7977568B2 (en) 2007-01-11 2011-07-12 General Electric Company Multilayered film-nanowire composite, bifacial, and tandem solar cells
US8574549B2 (en) * 2008-12-29 2013-11-05 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US20100166664A1 (en) * 2008-12-29 2010-07-01 General Electric Company Nanoparticle contrast agents for diagnostic imaging
US9399075B2 (en) 2008-12-29 2016-07-26 General Electric Company Nanoparticle contrast agents for diagnostic imaging
WO2011097824A1 (en) * 2010-02-12 2011-08-18 大连科林爱纳米科技有限公司 Preparation method of nano-gold particles used as contrast agent for x-ray or computerized tomography (ct)
ES2636908T3 (en) * 2010-04-27 2017-10-10 Ventana Medical Systems, Inc. Nanoparticle-antibody conjugates and procedures for producing and using said conjugates
US20130204121A1 (en) * 2010-07-16 2013-08-08 Thomas Lars Andresen Nanoparticle-guided radiotherapy
US10071174B2 (en) 2011-06-06 2018-09-11 Portland State University Bismuth particle X-ray contrast agents
MX362089B (en) * 2011-12-16 2019-01-07 Nanobiotix Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof.
US9459201B2 (en) 2014-09-29 2016-10-04 Zyomed Corp. Systems and methods for noninvasive blood glucose and other analyte detection and measurement using collision computing
EA201792560A1 (en) 2015-05-28 2018-06-29 Нанобиотикс NANOPARTICLES FOR APPLICATION AS A THERAPEUTIC VACCINE
US9554738B1 (en) 2016-03-30 2017-01-31 Zyomed Corp. Spectroscopic tomography systems and methods for noninvasive detection and measurement of analytes using collision computing
US20190001001A1 (en) * 2017-07-03 2019-01-03 General Electric Company Drug design for application-dependent payload, controlled pharmacokinetic distribution, and renal clearance
WO2023101745A2 (en) * 2021-09-09 2023-06-08 NU Planet Holding Co. Radioisotope generator, apparatus, system and method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10330288A (en) * 1997-06-03 1998-12-15 Mitsubishi Chem Corp Metal fine particle composite and contrast agent using the same
US6203778B1 (en) * 1998-12-08 2001-03-20 The Regents Of The University Of California Particulate radiopaque contrast agent for diagnostic imaging and microvascular characterization

Also Published As

Publication number Publication date
WO2003075961A3 (en) 2003-12-18
AU2002351240A8 (en) 2003-09-22
WO2003075961A2 (en) 2003-09-18

Similar Documents

Publication Publication Date Title
AU2002351240A1 (en) Gold nanoparticles used for x-rays imaging
AU2002348320A1 (en) X-ray fluoroscopic imaging
EP1593091A4 (en) High contrast optoacoustical imaging using nanoparticles
AU2003264858A1 (en) Reduced size imaging device
AU2003288947A1 (en) Tissue disorder imaging analysis
AU2002357361A1 (en) X-ray imaging device
AU2003218116A1 (en) Medical imaging systems
AU2002360766A1 (en) Methods for cancer imaging
AU2003272531A1 (en) Medical imaging systems
AU2003254058A1 (en) An imaging device for radiation treatment applications
IL166171A0 (en) Blood clot-targeted nanoparticles
AU2003282810A1 (en) Integrated multi-rail imaging system
AU2003244761A1 (en) Ultrasonic imaging device
AU2003302877A1 (en) X-ray system
AU2003296726A1 (en) Method and device for radiographic imaging
AU2003219359A1 (en) Imaging method
AU2003900924A0 (en) Imaging device
AU2003213186A1 (en) Independent component imaging
AU2003269226A1 (en) Particle imaging system
AU2003222014A1 (en) Miniaturized imaging device
AU2003240123A1 (en) Imaging apparatus
AU2003298022A1 (en) Particles for imaging cells
AU2003241706A1 (en) Solid imaging device
AU2003299241A1 (en) Solid-state x-ray detector
AU2002311347A1 (en) X-ray microscope

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase